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Neuropsychological performance in patients 
with subcortical stroke
Perfil neuropsicológico em pacientes com lesões vasculares subcorticais
Silviane Pinheiro Campos de Andrade1, Sônia Maria Dozzi Brucki2, Orlando Francisco Amodeo Bueno3,  
José Ibiapina Siqueira Neto4
Vascular cognitive impairment (VCI) has superseded vas-
cular dementia and multi-infarct dementia as the concept to be 
used in cognitive decline secondary to cerebrovascular disease1.
The prevalence of dementia increases with age, and the 
prevalence of vascular dementia in epidemiological stud-
ies varies between 22 and 26.28%2,3. An epidemiologic study 
in Brazil showed a prevalence of 9.3% for vascular dementia 
(VaD) among demented participants aged 64 years and older4. 
Studies in tertiary outpatient clinics report a prevalence of vas-
cular dementia between 24.9 and 32.25%5,6, and of 36.9% in a 
sample with presenile dementia7.
VCI is a risk factor for the development of dementia. Wentzel8 
observed that half of the subjects with vascular cognitive impair-
ment with no dementia (VCIND) developed dementia over a 
five-year period. The current findings suggest that poor mental 
flexibility and verbal retrieval in the context of preserved func-
tion in other domains may characterize the prodromal stage of 
VaD9. Cognitive impairment with vascular disease often occurs 
in domains of selective or divided attention, executive function 
( frontal lobe function) and processing speed10. 
Chui11 compared groups with dementia secondary to vas-
cular disease presenting ischemic subcortical lesions (VADIS) 
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ABSTRACT
Vascular cognitive impairment (VCI) is characterized by cognitive compromise predominantly of executive dysfunction. Objectives: To assess 
cognitive functions in VCI, focusing on executive functions, to observe functional losses in relation to activities of daily living (ADLs) and to 
detect early symptoms prior to the onset of dementia. Methods: We evaluated healthy subjects matched for gender, education and age to 
patients with diagnosis of subcortical vascular disease who had a stroke classified into three groups: 1) vascular lesions and no impairment; 
2) vascular cognitive impairment with no dementia (VCIND); 3) vascular dementia (VaD). Results and discussion: The performance on neu-
ropsychological tests differed among groups, worsening with increased impairment level. The probable VaD group demonstrated impaired 
performance in memory, processing speed and verbal production, while the VCIND group showed attention deficits. Conclusion: Impairment 
in executive functions and difficulties in ADLs allow us to differentiate levels of impairment in groups of subcortical vascular disease. 
Key words: cognitive impairment, vascular dementia, neuropsychological assessment, activities of daily living.
RESUMO
O comprometimento cognitivo vascular (CCV) é caracterizado por comprometimento cognitivo predominantemente sob a forma de disfunção 
executiva. Objetivos: Avaliar as funções cognitivas no CCV, enfocando as funções executivas, observar as perdas funcionais em relação às 
atividades cotidianas (AVDs) e detectar os primeiros sintomas antes do início da demência. Métodos: Foram avaliados indivíduos controles 
saudáveis pareados por sexo, escolaridade e idade com pacientes com diagnóstico de doença vascular subcortical que sofreram derrame 
classificados em três grupos: 1) lesões vasculares sem déficit; 2) comprometimento cognitivo vascular sem demência (CCVSD); 3) demência 
vascular (DV). Resultados e discussão: O desempenho em testes neuropsicológicos diferiu entre os grupos, sendo o desempenho tanto pior 
quanto maior o comprometimento. O grupo DV provável demonstrou desempenho prejudicado na memória, velocidade de processamento 
e produção verbal, enquanto o grupo CCVSD apresentou déficit de atenção. Conclusão: Prejuízos nas funções executivas e dificuldades em 
AVDs permitem diferenciar os níveis de comprometimento nos grupos de doença vascular subcortical.
Palavras-Chave: comprometimento cognitivo, demência vascular, avaliação neuropsicológica, atividades cotidianas.
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against those with Alzheimer disease (AD), and verified that 
the pattern of cognitive damage in VADIS is characterized by 
more extensive compromise of executive function, although 
with greater preservation in recognition memory. 
Several studies in the literature have sought to describe a 
model of cognitive profile for VaD, but, due to the varied forms 
of clinical manifestations, dependent on the types and loca-
tions of the vascular lesions, no single model exists for the en-
tity12. Rockwood et al.13 suggest that the cognitive syndrome of 
vascular disease is characterized by the predominance of exec-
utive dysfunction in contrast with the deficits of memory and 
language typical of patients with AD. Subcortical VaD presents 
a more homogeneous cognitive profile characterized by execu-
tive dysfunction and less severe impairment of memory12-15. 
The aims of this study were to evaluate the cognitive func-
tions in patients with subcortical vascular lesions, focusing 
on executive functions, and observe the functional losses with 
impairment in ADLs of each patient group in order to detect 
primary symptoms thereby enabling dementia prevention.
METHODS
Participants 
A total of 50 patients with vascular subcortical lesions (in-
cluding white periventricular matter, thalamus and basal gan-
glia lesions) were selected from medical files of an outpatient 
memory clinic of the Santa Marcelina Hospital and matched 
(according to age, gender and education) with 50 healthy elder-
ly controls. The patients who had subcortical lesions accord-
ing to medical records were invited to participate in the study 
and classified by an experienced neurologist. All patients were 
at a chronic phase more than three months after confirmed 
stroke. Medical history, neurological examination and MRI 
were performed in all subjects. Patients were classified into 
three groups according to scores obtained on the Mini-Mental 
State Examination (MMSE), based on the education level for 
the adapted Brazilian scale16, and on the Functional Activity 
Questionnaire (FAQ)17 (Table 1). This classification was later 
confirmed by the results of neuropsychological tests: no vascu-
lar cognitive impairment (NVCI): FAQ<4 and MMSE scores ≥ 
median value for education; VCIND: FAQ<4 and MMSE score 
between – 1.5 SDs and mean value for educational level; and 
VaD: patients with probable VaD according to NINDS-AIREN 
criteria16, FAQ>4 and MMSE<1.5SDs from the mean. 
The exclusion criteria for the patients were: aphasia; se-
vere paresis in dominant hand; uncorrected visual or hear-
ing deficit; use of medications that directly affect the central 
nervous system, such as benzodiazepines, anticholinergics 
drugs and neuroleptics; orthopedic or rheumatologic distur-
bances that could affect the exam; presence of areas of corti-
cal ischemia on magnetic resonance imaging.
Control group
Healthy control subjects were matched by age and educa-
tional level to each group of vascular patients. Controls were 
selected based on FAQ scores of less than 4 points and MMSE 
scores above the mean for each educational level. The control 
group included individuals drawn from the community, spouses 
and patients of the other specialties who fulfilled the inclusion 
criteria. Controls had no psychiatric or neurological diseases; no 
use of drugs with central nervous system action; no risk factors 
for cerebrovascular disease; no uncorrected sensory impairment; 
and no motor compromise due to orthopedic or rheumatologic 
conditions. Controls were matched with each patient group. 
After assessment of the functional activities using the 
FAQ and brief cognitive evaluation through the MMSE, pa-
tients and controls were submitted to a neuropsychological 
examination with a psychologist blinded to their condition. 
The demographic data (gender, age and education) of the 
study are shown in Table 2, with baseline MMSE and FAQ 
scores. We found no significant differences among the vari-
ables age, education and gender.
The study was approved by the Ethics Committees of 
the Federal University of São Paulo and of Santa Marcelina 
Hospital. All subjects gave prior written consent for partici-
pation in the study. 
Neuropsychological assessment
Neuropsychological assessment included digit span18: 
attention span, mental control and capacity to retain and 
manipulate verbal information; logical memory18: episodic 
memory in immediate and delayed recall; Wisconsin Card 
Sorting Test (WCST)18: the capacity to form concepts and 
mental flexibility; Trail Making Test (TMT) A and B18: speed 
of visuospatial search, attention and mental flexibility; Rey 
Complex Figure – copy and delayed recall18: planning, non-
verbal memory, visual and space perception and praxis.
It was applied the Clock Test – CLOX19, in which subjects are 
asked to “draw a clock showing 1.45” on the back of a score sheet, 
through which a black circle is displayed in the bottom right-
hand corner (CLOX 1). Once completed, the examiner draws the 
clock as required in front of the subject, placing 12, 6, 3 and 9 first, 
then setting the hands to ‘1.45’ and making them into arrows. The 
subject then has to copy the examiner’s clock (CLOX 2).
Table 1. Classification into three groups according to scores 
obtained on the Mini-Mental State Examination (MMSE), 
based on the education level for the adapted Brazilian scale.
NVCI VCIND VaD
FAQ<4 FAQ<4 FAQ>4
Education MMSE Education MMSE Education MMSE
Illiterates ≥20 Illiterates 18–20 Illiterates <18
1–4 ≥25 1–4 23–25 1–4 <23
5–8 ≥26 5–8 24–26 5–8 <24
9–11 ≥28 9–11 26–28 9–11 <26
≥12 ≥29 ≥12 ≥29 ≥12 <26
NVCI: no vascular cognitive impairment; VCIND: vascular cognitive 
impairment with no dementia; VaD: vascular dementia; FAQ: functional 
activity questionnaire.
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Moreover, in the assessment were include Stroop Test18: 
inhibition of a habitual answer rather than an unusual an-
swer, and to mental flexibility, impulsiveness and inhibitory 
control; verbal fluency: tests were accomplished by phonemic 
category – FAS18 is requested to utter as many words as pos-
sible starting with the letter ‘F’, ‘A’ and ‘S’; semantic category 
– animals18, it is expected that the patient state, within 60 sec-
onds, as many names of animals as possible; test of excluding 
letters20: assesses executive function while requiring control of 
impulsive answers. It consists of the generation of words for 
one minute, excluding a letter (in this case, letter E). 
Functional evaluation of the activities of daily living
Participants were evaluated according to the FAQ scores.
STATISTICAL ANALYSIS
The Statistical Package for the Social Sciences (SPSS) – version 
13.0 was used for data analysis. Non-parametric tests were used 
to evaluate non-categorical variables among groups. The Mann-
Whitney test verified possible differences among VaD, VCIND 
and NVCI groups and their respective controls. The Kruskal-
Wallis Test was applied to compare VaD, VCIND and NVCI 
groups for performance on neuropsychological tests. Differences 
among the groups were analyzed using the Mann-Whitney Test, 
and Spearman’s Correlation was performed to verify the relation-
ship between ADLs and the neuropsychological tests. The level of 
significance was set at 0.05. A forward stepwise logistic regression 
analysis (diagnosis of yes/no cognitive impairment as dependent 
variable) was performed to establish the independent predic-
tive ability of tests that presented p values less than 0.05 after the 
Mann-Whitney test. In order to perform the logistic regression 
analysis, we used the Mann-Whitney test to compare groups (yes 
or no cognitive impairment), to determine which tests could be 
elected for the regression model. To this, it was considered that a 
variable could be eligible if p<0.200. We applied the logistic regres-
sion analysis in function on the dependent variable ‘group’. Once 
we found the variables (neuropsychological tests) eligible to the 
modeling process through the application of logistic regression 
analysis, we constructed a regression model with four variables, 
which achieved the balance of the regression model.
RESULTS
Table 3 shows the mean and standard deviations on 
those tests revealing a significant difference among patient 
groups, with differences between each group. We found 
poorer performance associated with severity of clinical 
Table 2. Demographic data of study and control groups.
Variable
  Groups   
p-valueControls NVCI VCIND VaD
 n=50 n=12 n=10 n=28
Sex F=25  M=25 F=9  M=3 F=4  M =6 F=12  M=16 0.2651 
Age Mean (SD) 66.1 (9.1) 65.3 (10.3) 62.3 (9.2) 67.8 (8.1) 0.3782
Education Mean (SD) 5.9 (4.5) 7.8 (4.1) 4.9 (3.9) 5.3 (5.0) 0.1932
MMSE Mean (SD) 28.5 (2.1) 27.6 (1.7) 24.1 (4.1) 20.8 (4.5) <0.0012
1Chi-Square; 2Kruskal-Wallis Test; MMSE: Mini-Mental State Examination; NVCI: no vascular cognitive impairment; VCIND: vascular cognitive impairment with 
dementia; VaD: vascular dementia.
Table 3. Scores on neuropsychological tests and statistical differences among patient groups.
Variable
Groups
p-value*
NVCI VCIND VaD
n=10 n=12 n=28
Mean SD Mean SD Mean SD
Rey_copy 27.1a.c 6.1 17.8a 9.2 14.3 12.9 0.011
Rey_imed 8.6c 5.3 5.4 5.1 3.5 4.9 0.008
Rey_delayed 8.7c 5.5 4.4 4.5 2.4 3.9 0.003
Log_mem1 14.67c 4.6 11.7b 5.5 7.9b 6.8 0.003
Log_mem2 9.6a.c 5.4 5.0a 4.5 3.1 5.3 0.002
FAS 21.3c 11.6 13.4 5.8 12.0 9.3 0.034
CLOX2 12.8c 1.6 12.4b 1.9 8.6b 4.9 0.009
Animals 11.0c 2.5 10.1 4.7 7.6 3.2 0.015
Let_Exclud 10.4a.c 4.1 6.0a 4.5 5.5 4.2 0.005
Stroop1_Time 25.9c 9.4 31.9 11.9 53.5 29.7 0.002
MMSE 27.6a.c 1.7 24.1a 4.1 20.8 4.5 <0.001
FAQ 1.2c 1.4 3.2b 3.2 16.9b 8.3 <0.001
*Kruskal-Wallis Test; NVCI: no vascular cognitive impairment; VCIND: vascular cognitive impairment with no dementia; VaD: vascular dementia; MMSE: mini-mental state 
examination; FAQ: functional activity questionnaire. aStatistically significant differences between NVCI and VCIND groups (Mann-Whitney test). bSignificant difference 
between VCIND and probable VaD groups (Mann-Whitney test). cSignificant difference between NVCI and probable VaD groups (Mann-Whitney test). a, b, c p<0.05. 
344 Arq Neuropsiquiatr 2012;70(5):341-347
Table 4. Comparison among VaD, VCIND and NVCI groups with their respective controls.
Variable
NVCI Controls VCIND Controls VaD Controls
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Rey_time 536.8 (394.7) 377.3 (168.9) 415.0 (164.8)# 267.8 (113.9)# 406.0 (223.9) 375.8 (244.1)
Rey_copy 27.1 (6.1) 30.3 (7.4) 17.8 (9.2)# 28.6 (7.9)# 14.3 (12.9)# 26.6 (9.4)#
Rey_imed 8.6 (5.3) 10.5 (7.0) 5.4 (5.1) 10.0 (7.1) 3.5 (4.9)# 9.8 (6.8)#
Rey_delayed 8.7 (5.5) 10.0 (7.3) 4.4 (4.5) 8.5 (5.0) 2.4 (3.9)# 9.5 (6.9)#
Log_Mem1 14.7 (4.6) 14.4 (6.1) 11.7 (5.5) 12.6 (5.0) 7.9 (6.8)# 13.5 (6.2)#
Log_Mem2 9.6 (5.4) 9.9 (7.2) 5.0 (4.5) 7.4 (2.4) 3.1 (5.3)# 8.2 (6.4)#
FAS 21.3 (11.6)# 26.3 (5.7) 13.4 (5.9)# 22.0 (8.8)# 12.0 (9.3)# 24.3 (11.7)#
CLOX1 9.4 (2.6)# 11.4 (1.6) 6.1 (4.1) 8.1 (3.3) 6.0 (4.7)# 9.3 (4.1)#
CLOX2 12.8 (1.6) 13.1 (1.9) 12.4 (1.9) 13.1 (1.3) 8.6 (4.9)# 12.6 (1.9)#
Animals 11.0 (2.5) 13.4 (3.0) 10.1 (4.7)# 14.5 (4.2)# 7.6 (3.2)# 13.0 (4.1)#
TMT-A_Time 110.2 (59.9)# 70.3 (38.4) 168.2 (132.0)# 62.4 (36.0)# 257.9 (196.9)# 112.0 (82.0)#
TMT-A_Errors 0.2 (0.4) 0.1 (0.3) 0.4 (0.7) 0.0 (0.0) 0.7 (1.1) 0.5 (1.1)
TMT-B Time 311.9 (175.7)# 167.6 (94.0) 373.3 (162.5)# 158.1 (87.3)# 377.8 (220.0) 244.7 (168.4)
TMT-B_Errors 1.5 (1.2)# 0.3 (1.0) 0.8 (1.5) 0.4 (0.7) 1.5 (1.5) 0.9 (1.2)
Exclud_ Letter 10.4 (4.1) 13.4 (2.7) 6.0 (4.5)# 15.2 (4.5)# 5.5 (4.2)# 11.5 (4.5)#
Stroop1_Time 25.9 (9.4)# 18.4 (4.8) 31.9 (11.9)# 19.1 (4.1)# 53.5 (29.7)# 23.9 (10.2)#
Stroop1_Errors 0.5 (0.9) 0.0 (0.0) 0.2 (0.7) 0.0 (0.0) 1.1 (1.4)# 0.1 (0.4)#
Stroop2_Time 35.8 (10.5)# 26.3 (10.9) 47.3 (18.2)# 26.5 (8.7)# 76.5 (73.0)# 32.3 (13.9)#
Stroop2_Errors 0.3 (0.7) 0.0 (0.0) 0.6 (1.2) 0.0 (0.0) 1.3 (2.0)# 0.1 (0.3)#
Stroop3_Time 50.8 (15.7) 46.4 (18.6) 66.6 (24.9)# 41.2 (8.3)# 104.5 (96.1)# 50.5 (21.5)#
Stroop3_Errors 2.1 (1.6) 1.9 (1.6) 2.6 (2.1) 2.1 (2.2) 5.2 (4.9) 2.5 (2.5)
WCST_Categ 1.4 (0.9)# 3.2 (1.4) 1.0 (1.4)# 2.6 (1.2)# 1.1 (1.2)# 2.3 (1.0)#
WCST_ErPers 28.6 (16.0) 13.5 (8.2) 46.0 (1.4) 8.6 (4.7) 24.2 (15.0) 19.3 (10.7)
WCST_PerdaSet 0.6 (1.0) 0.6 (0.5) 1.3 (1.2) 0.6 (0.5) 0.4 (0.9) 0.5 (0.6)
Span_forward 4.9 (2.4) 6.5 (1.5) 3.6 (1.1) 5.0 (2.4) 4.2 (1.6)# 5.3 (2.1)#
Span_backward 3.6 (1.8) 3.3 (1.7) 2.6 (1.4) 4.0 (1.9) 2.9 (1.3)# 3.8 (1.5)#
*Mann-Whitney test; (p<0.05); VaD: vascular dementia; VCIND: vascular cognitive impairment with no dementia; NVCI: no vascular cognitive impairment; 
TMT: trail making test; WCST: wisconsin card sorting test. #significant difference between control and patient group. 
condition. There was no difference among groups on the 
following tests: trail making test, WCST, Stroop Test, for-
ward and backward digit span.
Table 4 depicts results of each group and their con-
trols, matched by age and educational level, on neu-
ropsychological tests. We observed significant statisti-
cal differences among VaD patients and their respective 
controls on verbal and nonverbal memory tests (imme-
diate and delayed recall), on visuospatial perception and 
construction tasks, on verbal fluency tests, speed pro-
cessing, categorization, abstract thinking, attention and 
working memory.
Comparison among VCIND patients and their controls 
revealed statistical differences on tests measuring visuoper-
ception and construction, verbal fluency, sustained atten-
tion, processing speed, categorization and abstraction. 
Comparisons between NVCI and the control group 
showed differences on tests of phonemic verbal fluency, vi-
sual construction, sustained attention, speed of processing, 
categorization and abstract thinking.
As expected, a negative correlation between FAQ scores 
(r=-0.387, p<0.001) was found. Correlations were performed 
to determine whether these measures (FAQ) were associated 
with neuropsychological functions (Table 5).
Based on results of the Mann-Whitney test, Animals, 
WCST_categ and Span_OI were selected for input to the lo-
gistic regression model. In general and concomitantly, the 
lower the value of Animals, of WSCT_Categ and of Span_OI 
and the larger the value on the FAQ, then the higher the prob-
ability of having the cognitive impairment when FAQ yields 
medium to high values, independently of the other variables. 
(Table 6).
These results showed that neuropsychological profiles 
differ among vascular severity groups.
DISCUSSION
Vascular cognitive impairment can be defined as cog-
nitive alterations due to cerebrovascular lesions, in which 
cognition is impaired at various degrees of severity21. We 
have classified patients with subcortical ischemic lesions 
by cognitive level based on a screening test (MMSE) and a 
functional activities questionnaire, with vascular dementia 
ranging from no evidence of cognitive impairment to vas-
cular dementia. 
The MMSE cutoff scores overlapped between groups, 
maybe due to lack of sensitivity to subcortical cognitive 
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impairment or owing to the inability to distinguish slight dif-
ferences among VCI profiles, but largely due to an expected 
overlap of cutoff scores. Notwithstanding, the groups pre-
sented clear differences on many cognitive measures, show-
ing a clear-cut division.
Our results showed progressive impairment in many ex-
ecutive functions from the NVCI to the probable VaD group, 
in phonemic fluency, visuospatial skills and sustained at-
tention, strategy and constructional praxis, divided atten-
tion, categorization and abstract thinking tests, as well as 
in verbal and nonverbal memory tests. It is important to 
emphasize that TMT-B was greatly compromised in the 
Probable VaD group, with many patients unable to com-
plete the task, proving to be a difficult type of test for low 
educated subjects.
Significant differences were found between the studied 
groups and their controls, with the probable VaD group be-
ing most impaired in relation to their controls. As observed, 
the NVCI group had poorer performance than their controls 
on many cognitive measures, particularly in relation to verbal 
Table 6. Logistic regression.
Variable Coefficient S.E. Z Odds Ratio
95%CI
p-value
Lower Upper
Animais -0.421 0.274 2.361 0.656 0.383 1.123 0.124
WCST_categ -2.071 1.087 3.634 0.126 0.015 1.060 0.057
Span_OI 1.556 0.820 3.601 4.740 0950 23.650 0.058
WCST: wisconsin card sorting test; SE: standard error.
fluency, visuospatial skills and sustained attention, and on 
strategy and constructional praxis, divided attention, catego-
rization and abstract thinking. This indicates that early eval-
uation of these functions could prevent more serious condi-
tions, as patients were functionally adequate. According to 
Laukka22, cognitive deficits could be presented in a preclini-
cal phase of VaD, resulting from circulatory disturbances that 
could affect cerebral function before dementia is diagnosed. 
In our study, we found poorer results in patients with no cog-
nitive impairment on the screening test and with preserved 
ADLs (NVCI group), perhaps suggesting that these tests are 
effective at screening for very mild cognitive impairments in 
patients with ischemic subcortical lesions. 
 All patient groups performed worse than their controls 
on tests of verbal fluency, processing speed and abstract 
thinking akin to other reports19 which compared healthy con-
trols to VCI and VaD patients.
The VCIND group had impaired performance in rela-
tion to their controls on tests related to cortico-subcortical 
pathways, although demonstrated intact functional ADL. 
These patients presented depressive symptoms that did 
not correlate with neuropsychological performance. This 
fact allows us to make some inferences in VCIND profile 
subjects, for example, that there is early compromise of ex-
ecutive functions which cannot be explained by depressive 
symptoms alone. Pantoni and colleagues12 showed that the 
VCIND group demonstrated significant difficulties on mea-
sures of cognitive flexibility, verbal retrieval and verbal rec-
ognition memory, but not on measures of confrontational 
naming or verbal fluency. The probable VaD group was im-
paired on all cognitive measures assessed, suggesting that 
poor cognitive flexibility and verbal retrieval in the context 
of preserved function in other domains may characterize 
the prodromal stage of VaD.
Our findings comparing VCIND and probable VaD groups 
were similar to those of the study by Stephens et al.23 who 
described compromise of executive functions in both these 
patient groups ascribing this to early damage in VCI. Other 
studies have reported similar findings, in addition to decline 
in ADLs and frequent depressive symptoms24,25.
However, we noted that in mild stages of impairment, 
such as in VCIND, there is significant compromise of visual 
construction, verbal fluency, visuospatial skills, attention, ab-
straction thinking, inhibitory control and processing speed. 
The VCIND group presented impairment in mental flex-
ibility whereby this group committed the largest number of 
Neuropsychological tests 
Correlation coefficient/p value
FAQ
r p-value
Rey_copy -0.443 <0.001
Rey_imed -0.414 <0.001
Rey_delayed -0.488 <0.001
Log_Mem1 -0.430 <0.001
Log_Mem2 -0.522 <0.001
FAS -0.563 <0.001
CLOX1 -0.353 <0.001
CLOX2 -0.418 <0.001
Animals -0.549 <0.001
TrailA_Time 0.462 <0.001
TrailB_Time 0.413 0.001
Let_Exclud -0.576 <0.001
Stroop1_Time 0.616 <0.001
Stroop1_Errors 0.518 <0.001
Stroop2_Time 0.492 <0.001
Stroop2_Errors 0.539 <0.001
Stroop3_Time 0.440 <0.001
Stroop3_Errors 0.336 0.003
WCST_Categ -0.500 <0.001
Span_forward -0.246 0.015
Span_backward -0.245 0.015
*Spearman’s correlation; FAQ: functional activity questionnaire; WCST: 
wisconsin card sorting test.
Table 5. Correlation among scores on FAQ and neuropsychological 
tests.
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perseverative errors on the WCST. This finding is in agree-
ment with the study of Garret et al.9 who observed sig-
nificant difficulties in mental flexibility in their sample of 
VCIND patients. 
In the study by Stephens et al.23, deficits in attention 
and executive function were observed in patients with 
stroke, but without cognitive impairment (NVCI), com-
pared to controls. Comparing these patients with a group 
of patients with vascular cognitive impairment without 
dementia, they observed that the latter had greater im-
pairment in tests of executive functions, memory and lan-
guage. Our comparison between NVCI and VCIND groups 
yielded the same results as the study by Stephens, since 
our VCIND group was significantly more impaired on tests 
of memory and language. In our study, we also detected 
significant differences between the NVCI group and con-
trols on the tests evaluating attention and executive func-
tions (TMT-B, Stroop and WCST).
Comparison of our VCIND and probable VaD groups 
yielded results similar to those found by Stephens. Our pa-
tients differed in episodic memory, visuoconstructive ability 
and ADLs.
We observed a pattern of decreased cognitive functions 
according to the degree of early impairment in executive 
functions and verbal fluency, and deficits in visual-spatial 
skills, divided attention and abstract thinking in individuals 
with vascular lesions. These deficits were greater in subjects 
with VCIND than in ones with NVCI, and we also observed 
compromise in planning and mental control, even in indi-
viduals with VaD in that all the tests of executive functions 
were impaired, indicating early impairment of dopaminer-
gic and cholinergic pathways that traverse the subcortical 
white matter26.
Depressive symptoms are common in patients with cere-
brovascular disease, and cognitive impairment is common 
in geriatric depression. Also, depressed individuals with co-
morbid cognitive impairment are at increased risk for a num-
ber of adverse medical, psychiatric and cognitive outcomes27. 
Therefore, it is always important to differentiate executive 
dysfunction and depressive symptoms for adequate thera-
peutic conduct. 
We also noted significant correlation between FAQ scores 
and neuropsychological measures. The results of our study re-
veal that patients with subcortical vascular lesions have cog-
nitive impairment, mainly in executive functions, difficulties 
in ADLs and presence of depressive symptoms, indicating 
that searching for these types of signs and symptoms proves 
to be effective for early diagnosis of VCI. 
Some patients presented very mild cognitive impair-
ment, that did not result in significant ADL difficulties, and 
few depressive symptoms. Such cases in our survey were de-
noted as NVCI. In these subjects, only a neuropsychological 
evaluation verified decreased performance. These findings 
could point to a need for a more detailed evaluation in pa-
tients with subcortical lesions for early diagnosis. In these 
cases, it is possible that neuropsychological evaluation 
could represent a gold standard method for diagnosis at 
basal measurement in order to follow cognitive outcome. 
Some limitations should be observed in our study. These 
concern the severity of subcortical ischemic lesions, since no 
ranking scale was used to evaluate their presence at the time 
of evaluation, precluding correlation of lesion severity with 
cognitive impairments. Unfortunately, we did not use quan-
titative scales of white matter hyperintensities or quantifi-
cation of brain volume loss. Nevertheless, our patients were 
carefully selected with respect to the presence of subcorti-
cal lesions, seen on magnetic resonance imaging. All patients 
had been at a chronic phase for more than three months af-
ter confirmed stroke. The sample size was relatively small in 
the VCI and NVCI groups, but patients were highly selected. 
We believe that limitations regarding the number of patients 
were minimized by matching each type of patient group with 
its own control group, providing a neuropsychological pro-
file with considerable consistency. Possible education influ-
ence on majority of the tests was minimized homogenizing 
the samples by matching for schooling.
Our results allow us to conclude that there is a continu-
um in cognitive profiles, from mild signs of cognitive impair-
ment to incontestable dementia, despite the fact this was a 
transversal study. The pattern of cognitive deficit of VCIND 
and VaD are similar, except that in the probable VaD group 
the deficits tend to be greater than in the VCIND group. All 
patient groups presented difficulties on tests evaluating ex-
ecutive functions (planning, mental control, abstraction, per-
severation, inhibitory control and processing speed), albeit to 
different degrees. 
The results showed that executive impairments mani-
fest early in mild impairment among subcortical ischemic 
lesion patients, who also present an increased frequency of 
depressive symptoms, as well as some difficulties in ADLs. 
Evaluation of functional activity seems to be a valuable ap-
proach for early detection of vascular cognitive impairment.  
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